GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Toleranzia AB (OSTO:TOL) » Definitions » Net Investment Income

Toleranzia AB (OSTO:TOL) Net Investment Income


View and export this data going back to 2015. Start your Free Trial

What is Toleranzia AB Net Investment Income?

Net Investment Income only applies to insurance companies.


Toleranzia AB Business Description

Traded in Other Exchanges
N/A
Address
Arvid Wallgrens backe 20, 8th floor, Gothenburg, SWE, SE-413 46
Toleranzia AB is a Swedish biotechnology Company. The company develops drugs that harness the power of the immune system to treat autoimmune orphan diseases The company's drug candidate, TOL2, is being developed for the treatment of the autoimmune neuromuscular disease myasthenia gravis, an orphan disease.